SCHEMBL14068682

SCHEMBL14068682

CC(=O)N(Cc1ccccc1Cl)Cc1cc2cccc(C)c2[nH]c1=O

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 9/20 0.61
KDM4E B2RXH2 8/20 0.61
USP2 O75604 3/20 0.61
ALDH1A1 P00352 8/20 0.57
KMT2A Q03164 5/20 0.56
MEN1 O00255 4/20 0.56
NPC1 O15118 1/20 0.56
MAPK1 P28482 1/20 0.55
TP53 P04637 2/20 0.54
MAPT P10636 1/20 0.54
ALOX15 P16050 1/20 0.54
TSHR P16473 3/20 0.52
PKM P14618 2/20 0.52
RECQL P46063 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
THRB P10828 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14068637 0.88 ALDH1A1 (0.58) HSD17B10KDM4EUSP2ALDH1A1KMT2A
SCHEMBL14068803 0.86 ALDH1A1 (0.68) HSD17B10KDM4EUSP2ALDH1A1KMT2A
SCHEMBL14068800 0.85 KDM4E (0.71) HSD17B10KDM4EALDH1A1KMT2AMEN1
SCHEMBL14068807 0.84 ALDH1A1 (0.54) HSD17B10KDM4EUSP2ALDH1A1KMT2A
SCHEMBL14068384 0.81 KDM4E (0.59) HSD17B10KDM4EALDH1A1KMT2AMEN1
SCHEMBL4745033 0.79 ALDH1A1 (0.61) HSD17B10KDM4EUSP2ALDH1A1KMT2A
SCHEMBL4746968 0.78 RXFP1 (0.63) HSD17B10KDM4EUSP2ALDH1A1KMT2A
SCHEMBL16491220 0.77 HSD17B10 (0.62) HSD17B10KDM4EUSP2ALDH1A1KMT2A
SCHEMBL4743064 0.76 KDM4E (0.71) HSD17B10KDM4EALDH1A1KMT2AMEN1
SCHEMBL13496419 0.76 HSD17B10 (0.68) HSD17B10KDM4EUSP2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO disclosed